Business Segments Jointown Pharmaceutical Group Co., Ltd
Equities
600998
CNE100000W45
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.030 CNY | -0.40% |
|
-7.71% | -1.76% |
| Jun. 06 | Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection | MT |
| May. 19 | Jointown to Invest 23 Million Yuan Into Pharma-Focused Investment Fund | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Distribution | 139B | 151B | 176B | 146B | 147B | |||||
Total Assets | 137B | 145B | 161B | 115B | 137B | |||||
Interest Expense | -1.35B | -1.48B | -1.52B | -1.29B | -1.25B | |||||
CAPEX | -1.98B | 189M | -1.1B | - | - | |||||
EBT | 5.68B | 4.59B | 4.19B | 6.35B | 7.65B | |||||
D&A | 425M | 512M | 583M | - | - | |||||
Industrial | 1.72B | 1.88B | 2.31B | 3.38B | 4.09B | |||||
Total Assets | 2.79B | 3.5B | 4.3B | 4.37B | 5.01B | |||||
Interest Expense | -21.67M | -21.01M | -22.88M | -18.13M | -22.83M | |||||
CAPEX | -2.31M | -121M | -125M | - | - | |||||
EBT | 83M | 149M | 163M | 124M | 136M | |||||
D&A | 59.4M | 75.16M | 76.2M | - | - | |||||
Retail | 2.74B | 1.84B | 2.26B | 2.82B | 2.97B | |||||
Total Assets | 1.58B | 1.5B | 1.99B | 1.37B | 1.45B | |||||
Interest Expense | -1.78M | -5.71M | -6.02M | -7.49M | -11.22M | |||||
CAPEX | -8.93M | -14.63M | -34.91M | - | - | |||||
EBT | 109M | -65.65M | 62.47M | 29.05M | -26.25M | |||||
D&A | 15.03M | 53.17M | 38.04M | - | - | |||||
Healthcare Segment | 457M | 384M | 290M | 275M | 329M | |||||
Total Assets | 2.48B | 3.29B | 3.49B | 3.22B | 2.88B | |||||
Interest Expense | -8.74M | -36.51M | -43.61M | -32.66M | -28.16M | |||||
CAPEX | -113M | -184M | 42.88M | - | - | |||||
EBT | -63.13M | 69.75M | -2.4M | -102M | -40.5M | |||||
D&A | 32.77M | 49.41M | 47.61M | - | - | |||||
Other Segment | 57.63M | 70.06M | 193M | 245M | 241M | |||||
Total Assets | 3B | 3.79B | 4.52B | 18.48B | 5.81B | |||||
Interest Expense | -5.1M | -3.38M | -15.23M | -37.84M | -15.23M | |||||
CAPEX | -242M | -267M | -394M | - | - | |||||
EBT | 25.16M | 20.58M | 80.66M | -5.22M | 629M | |||||
D&A | 26M | 28.75M | 38.29M | - | - | |||||
Intersegment Offset | -32.88B | -32.8B | -40.2B | -2.57B | -2.85B | |||||
Total Assets | -66.19B | -70.89B | -83.35B | -49.32B | -50.14B | |||||
Interest Expense | 362M | 401M | 389M | 72.62M | 40.76M | |||||
EBT | -1.51B | -1.4B | -1.65B | -3.41B | -4.71B | |||||
D&A | -1.59M | -370K | -652K | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Eastern China | 31.13B | 35.35B | 39.75B | 42.79B | 44.59B | |||||
Central China | 25.47B | 27.02B | 30.92B | 33.14B | 33.21B | |||||
North China | 16.67B | 19.32B | 22.9B | 26.52B | 26.4B | |||||
Northwest China | 9.77B | 10.34B | 12.11B | 13.98B | 13.92B | |||||
Southwest China | 9.61B | 10.81B | 12.99B | 13.22B | 13.82B | |||||
South China | 10.15B | 11.55B | 13.39B | 12.47B | 12.65B | |||||
North East China | 6.94B | 7.85B | 8.19B | 7.84B | 7.02B | |||||
Other Areas | 1.11B | 162M | 163M | 186M | 204M | |||||
Internal Offset | - | - | - | - | - | |||||
China | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
